Routine Postoperative Antibiotic Prophylaxis Offers No Benefit after Hepatectomy-A Systematic Review and Meta-Analysis.
antibiotic resistance
antibiotic stewardship
antibiotics
hepatectomy
infection
liver surgery
meta-analysis
surgical site infection
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
12 May 2022
12 May 2022
Historique:
received:
16
04
2022
revised:
09
05
2022
accepted:
10
05
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Prophylactic antibiotics are frequently administered after major abdominal surgery including hepatectomies aiming to prevent infective complications. Yet, excessive use of antibiotics increases resistance in bacteria. The aim of this systematic review and meta-analysis is to assess the efficacy of prophylactic antibiotics after hepatectomy (postoperative antibiotic prophylaxis, POA). This systematic review and meta-analysis were completed according to the current PRISMA guidelines. The protocol has been registered prior to data extraction (PROSPERO registration Nr: CRD42021288510). MEDLINE, Web of Science and CENTRAL were searched for clinical reports on POA in hepatectomy restrictions. A random-effects model was used for synthesis. Methodological quality was assessed with RoB2 and ROBINS-I. GRADE was used for the quality of evidence assessment. Nine comparative studies comprising 2987 patients were identified: six randomized controlled trials (RCTs) and three retrospectives. POA did not lead to a reduction in postoperative infective complications or have an effect on liver-specific complications-post-hepatectomy liver failure and biliary leaks. POA over four or more days was associated with increased rates of deep surgical site infections compared to short-term administration for up to two days (OR 1.54; 95% CI [1.17;2.03]; Routine POA cannot be recommended after hepatectomy since it does not reduce postoperative infection or liver-specific complications but contributes to resistance in bacteria. Studies into individualized risk-adapted antibiotic prophylaxis strategies are needed to further optimize perioperative treatment in liver surgery.
Sections du résumé
BACKGROUND
BACKGROUND
Prophylactic antibiotics are frequently administered after major abdominal surgery including hepatectomies aiming to prevent infective complications. Yet, excessive use of antibiotics increases resistance in bacteria. The aim of this systematic review and meta-analysis is to assess the efficacy of prophylactic antibiotics after hepatectomy (postoperative antibiotic prophylaxis, POA).
METHOD
METHODS
This systematic review and meta-analysis were completed according to the current PRISMA guidelines. The protocol has been registered prior to data extraction (PROSPERO registration Nr: CRD42021288510). MEDLINE, Web of Science and CENTRAL were searched for clinical reports on POA in hepatectomy restrictions. A random-effects model was used for synthesis. Methodological quality was assessed with RoB2 and ROBINS-I. GRADE was used for the quality of evidence assessment.
RESULTS
RESULTS
Nine comparative studies comprising 2987 patients were identified: six randomized controlled trials (RCTs) and three retrospectives. POA did not lead to a reduction in postoperative infective complications or have an effect on liver-specific complications-post-hepatectomy liver failure and biliary leaks. POA over four or more days was associated with increased rates of deep surgical site infections compared to short-term administration for up to two days (OR 1.54; 95% CI [1.17;2.03];
CONCLUSION
CONCLUSIONS
Routine POA cannot be recommended after hepatectomy since it does not reduce postoperative infection or liver-specific complications but contributes to resistance in bacteria. Studies into individualized risk-adapted antibiotic prophylaxis strategies are needed to further optimize perioperative treatment in liver surgery.
Identifiants
pubmed: 35625294
pii: antibiotics11050649
doi: 10.3390/antibiotics11050649
pmc: PMC9138010
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Br J Surg. 1998 Apr;85(4):489-93
pubmed: 9607529
Surg Infect (Larchmt). 2017 Feb/Mar;18(2):149-156
pubmed: 27906606
PLoS One. 2020 Jan 10;15(1):e0227139
pubmed: 31923281
J Antimicrob Chemother. 2007 May;59(5):964-70
pubmed: 17329271
Antibiotics (Basel). 2022 May 12;11(5):
pubmed: 35625294
ANZ J Surg. 2013 Sep;83(9):641-5
pubmed: 22946966
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1083-92
pubmed: 26242369
JAMA Surg. 2016 Apr;151(4):323-9
pubmed: 26580850
Surg Clin North Am. 2014 Dec;94(6):1245-64
pubmed: 25440122
Ann Surg. 2018 Jan;267(1):142-148
pubmed: 27759623
Cell Mol Immunol. 2016 May;13(3):267-76
pubmed: 27063467
J Gastroenterol Hepatol. 2021 Sep;36(9):2531-2539
pubmed: 33948991
HPB (Oxford). 2022 Mar;24(3):353-358
pubmed: 34330644
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Gastrointest Surg. 2019 Nov;23(11):2163-2173
pubmed: 30719675
Surg Infect (Larchmt). 2006;7 Suppl 1:S7-11
pubmed: 16834549
Langenbecks Arch Surg. 2021 Sep;406(6):1723-1731
pubmed: 34129108
Surg Infect (Larchmt). 2018 Apr;19(3):326-333
pubmed: 29461929
Medicine (Baltimore). 2019 Jun;98(26):e16241
pubmed: 31261586
Ann Gastroenterol Surg. 2019 May 30;3(5):506-514
pubmed: 31549010
J Hosp Infect. 2008 Nov;70 Suppl 2:3-10
pubmed: 19022115
Surg Today. 2019 Oct;49(10):859-869
pubmed: 31030266
HPB (Oxford). 2014 May;16(5):407-21
pubmed: 23991862
J Hepatobiliary Pancreat Sci. 2021 Oct 8;:
pubmed: 34623761
Intensive Care Med. 2018 Mar;44(3):300-310
pubmed: 29484469
Am Surg. 2014 Sep;80(9):878-83
pubmed: 25197874
Am J Surg. 2013 Jul;206(1):8-15
pubmed: 23706259
Curr Top Microbiol Immunol. 2016;398:3-33
pubmed: 27406189